The World Health Organization Guidance on Clinical Management of Crimean- Congo Haemorrhagic Fever

Dr. Elie Akl, the director of the AUB GRADE center, co-chaired the panel meeting for the development of the World Health Organization (WHO) guidance on clinical management of Crimean-Congo Haemorrhagic Fever (CCHF).

CCHF is one of the most widespread tick-borne diseases in humans and endemic in areas including the middle east and has a case-fatality rate between 10% and 40%. WHO has included CCHF in its list of priority pathogens for which urgent research and developmental action is required.

The panel meeting was co-hosted by the Robert Koch Institute in Germany and the WHO Experts Network Unit (formerly the Epidemic clinical Management Unit) and was held on April 4-5 in Berlin, Germany.

The American Society of Hematology (ASH) guidelines on management of venous thromboembolism in patients with cancer

Ms. Lara Kahale, the coordinator of the Clinical Epidemiological Unit at the Clinical Research Institute, contributed to the second panel meeting of the American Society of Hematology (ASH guidelines) that developed recommendations for the management of venous thromboembolism in patients with cancer. Ms. Kahale and the AUB team coordinated the work related to evidence synthesis and evidence presentation for that guideline. The meeting took place in the ASH headquarters in Washington D.C. on March 1 and 2, 2017 and included meetings for expert panels of an additional two of the ten guidelines being developed as part of this project.